Gregory Scott Duncan Cor Medix Inc. (CRMD) insider trading activity

Gregory Scott Duncan is Director of CorMedix Inc.. Currently has a direct ownership of 25,000 shares of CRMD, which is worth approximately $281,500. The most recent transaction as insider was on Jan 17, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K

n/a 3M change

n/a 12M change

Total Value Held $281,500

Gregory Scott Duncan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 17 2025	BUY Grant, award, or other acquisition	-	25,000 Added 50.0%	25,000 Common Stock

Also insider at

VIRI

Virios Therapeutics, Inc. Healthcare

CHIEF EXECUTIVE OFFICER

GSD